123 related articles for article (PubMed ID: 22475903)
21. 18F-FDG imaging of the primary breast leiomyosarcoma and follow-up lung metastasis.
Pai M; Yoon SN
Clin Nucl Med; 2013 Mar; 38(3):e152-4. PubMed ID: 23354027
[TBL] [Abstract][Full Text] [Related]
22. Pulmonary amyloidosis in a patient with Langerhans cell histiocytosis: diagnostic dilemma on 18F-FDG PET/CT.
Mukherjee A; Dhull VS; Sharma P; Parida GK; Jain S; Pal L; Kumar R
Clin Nucl Med; 2014 Apr; 39(4):e263-4. PubMed ID: 24097004
[TBL] [Abstract][Full Text] [Related]
23. [Diagnostic value of (18)F-FDG PET/CT imaging plus serum tumor marker assays for pulmonary lesions and clinical significance of SUVmax].
Zhang TM; Zhang LM; Liu Y; Zhang ZF; Wang CL
Zhonghua Yi Xue Za Zhi; 2012 Nov; 92(41):2901-4. PubMed ID: 23328236
[TBL] [Abstract][Full Text] [Related]
24. False-negative rate after positron emission tomography/computer tomography scan for mediastinal staging in cI stage non-small-cell lung cancer.
Gómez-Caro A; Boada M; Cabañas M; Sanchez M; Arguis P; Lomeña F; Ramirez J; Molins L
Eur J Cardiothorac Surg; 2012 Jul; 42(1):93-100; discussion 100. PubMed ID: 22290911
[TBL] [Abstract][Full Text] [Related]
25. PET/MR imaging in the detection and characterization of pulmonary lesions: technical and diagnostic evaluation in comparison to PET/CT.
Rauscher I; Eiber M; Fürst S; Souvatzoglou M; Nekolla SG; Ziegler SI; Rummeny EJ; Schwaiger M; Beer AJ
J Nucl Med; 2014 May; 55(5):724-9. PubMed ID: 24652827
[TBL] [Abstract][Full Text] [Related]
26. Significance of a new fluorodeoxyglucose-positive lesion on restaging positron emission tomography/computed tomography after induction therapy for non-small-cell lung cancer.
Collaud S; Lardinois D; Tischler V; Steinert HC; Stahel R; Weder W
Eur J Cardiothorac Surg; 2012 Mar; 41(3):612-6. PubMed ID: 22219415
[TBL] [Abstract][Full Text] [Related]
27. Prognostic value of whole-body total lesion glycolysis at pretreatment FDG PET/CT in non-small cell lung cancer.
Chen HH; Chiu NT; Su WC; Guo HR; Lee BF
Radiology; 2012 Aug; 264(2):559-66. PubMed ID: 22692034
[TBL] [Abstract][Full Text] [Related]
28. Detection of an asymptomatic right-ventricle cardiac metastasis from a small-cell lung cancer by F-18-FDG PET/CT.
Orcurto MV; Delaloye AB; Letovanec I; Martins Favre M; Prior JO
J Thorac Oncol; 2009 Jan; 4(1):127-30. PubMed ID: 19096320
[TBL] [Abstract][Full Text] [Related]
29. Thoracic staging in lung cancer: prospective comparison of 18F-FDG PET/MR imaging and 18F-FDG PET/CT.
Heusch P; Buchbender C; Köhler J; Nensa F; Gauler T; Gomez B; Reis H; Stamatis G; Kühl H; Hartung V; Heusner TA
J Nucl Med; 2014 Mar; 55(3):373-8. PubMed ID: 24504054
[TBL] [Abstract][Full Text] [Related]
30. Maxillofacial Spindle Cell Sarcoma With Lung Metastases on FDG PET/CT Imaging.
Wu X; Zhang C; Huang Y; Wang H; Jiang L
Clin Nucl Med; 2018 Sep; 43(9):703-704. PubMed ID: 30015665
[TBL] [Abstract][Full Text] [Related]
31. Pleomorphic carcinoma of the lung with intrapulmonary aerogenic metastases on FDG PET.
Sonomura T; Noda Y; Sato M; Sanda H; Ishii S; Kawai N; Minamiguchi H; Nakai M; Takeuchi T; Takasaka I; Kishi K
Clin Nucl Med; 2010 Sep; 35(9):717-9. PubMed ID: 20706051
[TBL] [Abstract][Full Text] [Related]
32. A case of pulmonary choriocarcinoma metastasis with unusual FDG-PET and CT findings: correlation with pathology.
Maruoka Y; Abe K; Baba S; Isoda T; Matsuo Y; Kubo Y; Ogawa S; Yano T; Sasaki M; Honda H
Ann Nucl Med; 2012 Dec; 26(10):835-9. PubMed ID: 22893003
[TBL] [Abstract][Full Text] [Related]
33. Benign intrapulmonary schwannoma: aspect on F-18 fluorodeoxyglucose PET/CT.
Gonzalez M; Prior JO; Rotman S; Ris HB; Krueger T
Clin Nucl Med; 2011 Jun; 36(6):465-7. PubMed ID: 21552027
[TBL] [Abstract][Full Text] [Related]
34. Value of PET/CT imaging for diagnosing pulmonary metastasis of colorectal cancer.
Bamba Y; Itabashi M; Kameoka S
Hepatogastroenterology; 2011; 58(112):1972-4. PubMed ID: 22024070
[TBL] [Abstract][Full Text] [Related]
35. Metastatic colon cancer to the lung with no detectable primary tumor, mimicking advanced primary lung cancer on F-18 FDG PET/CT imaging.
Kim HW; Won KS; Kwon KY; Choi BW; Zeon SK
Clin Nucl Med; 2010 Mar; 35(3):184-6. PubMed ID: 20173453
[TBL] [Abstract][Full Text] [Related]
36. Evaluation of ¹⁸F-fluorodeoxyglucose uptake in enlarged mediastinal lymph nodes in patients with lung cancer.
Ji C; Zhang B; Zhu W; Ling C; Hu X; Chen Y; Huang J; Guo L; Xu H
Int J Clin Exp Pathol; 2014; 7(11):8227-34. PubMed ID: 25550877
[TBL] [Abstract][Full Text] [Related]
37. F18-FDG PET-CT analyses of small peripheral adenocarcinoma of the lung.
Takahashi Y; Takashima S; Watanabe S; Tomita Y; Hakucho T; Miyake C; Morimoto D; Hosoki T; Nakanishi K; Higashiyama M
Acta Radiol; 2013 Mar; 54(2):164-8. PubMed ID: 23138022
[TBL] [Abstract][Full Text] [Related]
38. Diagnostic value of fluorine 18 fluorodeoxyglucose positron emission tomography/computed tomography for the detection of metastases in non-small-cell lung cancer patients.
Wu Y; Li P; Zhang H; Shi Y; Wu H; Zhang J; Qian Y; Li C; Yang J
Int J Cancer; 2013 Jan; 132(2):E37-47. PubMed ID: 22890912
[TBL] [Abstract][Full Text] [Related]
39. Usefulness of (18)F-FDG PET/CT in a rare case of malignant pseudothyroiditis.
Treglia G; Del Ciello A; Fadda G; Calcagni ML
Clin Nucl Med; 2014 Feb; 39(2):e163-5. PubMed ID: 23531733
[TBL] [Abstract][Full Text] [Related]
40. Targeted lymph node biopsy in mediastinoscopy using 3D FDG-PET/CT movies: a feasibility study.
Siepel FJ; de Bruin WI; van Duyn EB; Steenvoorde P; Wagenaar NR; Slump CH; van Dalen JA
Nucl Med Commun; 2012 Apr; 33(4):439-44. PubMed ID: 22311052
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
